NewsBenzingaJP Morgan mantiene la recomendación de sobreponderar sobre Eli Lilly y eleva el precio objetivo a 1650 dólares. JP Morgan mantiene la recomendación de sobreponderar sobre Eli Lilly y eleva el precio objetivo a 1650 dólares. Benzinga 2026.10.30 22:14 (GMT+0) Open on Benzinga Other news $100 Invested In TechnipFMC 5 Years Ago Would Be Worth This Much Today JP Morgan Maintains Neutral on Teck Resources, Raises Price Target to $63 JP Morgan Maintains Underweight on T. Rowe Price Group, Raises Price Target to $107 JP Morgan Maintains Neutral on State Street, Raises Price Target to $192.5 JP Morgan Maintains Overweight on Saia, Raises Price Target to $468 ASML vs. Applied Materials: One Is Growing Twice as Fast, but I’d Buy The Other Instead
